Evidence map›Paper›PMID 12452376›Full record

ArticleDigestive diseases and sciences2002

Enzyme histochemistry is useful to assess viability of tumor tissue after microwave coagulation therapy (MCT): metastatic adenocarcinoma treated by lateral segmentectomy after MCT.

Ken-Ichi Mukaisho, Yoshimasa Kurumi, Hiroyuki Sugihara, Shigeyuki Naka, Sumihiro Kamitani, Yasuhiro Tsubosa, Suzuko Moritani, Yoshihiro Endo, Kazuyoshi Hanasawa, Shigehiro Morikawa and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ken-Ichi MukaishoFirst department of Surgery, Shiga University of Medical Science, Shiga, Ohtsu, Japan.
Yoshimasa Kurumi
Hiroyuki Sugihara
Shigeyuki Naka
Sumihiro Kamitani
Yasuhiro Tsubosa
Suzuko Moritani
Yoshihiro Endo
Kazuyoshi Hanasawa
Shigehiro Morikawa
Toshiro Inubushi
Takanori Hattori
Tohru Tani
Shiga University of Medical Science · JPShiga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on a case of metastatic adenocarcinoma of liver that was removed and examined histochemically after microwave coagulation therapy (MCT). The patient was a 65-year-old woman who had a metastatic tumor in the liver (S3) after high anterior resection due to a rectal adenocarcinoma and received MCT against the tumor. One month after MCT, multiple metastatic tumors were detected by abdominal computed tomography (CT) scan. As it was difficult to control them by MCT alone, we performed lateral segmentectomy. To assess the effects of microwave ablation on cellular viability of metastatic tumor, we used enzyme histochemistry for acid phosphatase (AcP), which is positive in macrophages infiltrating in the tumor. In a part of the ablated area of resected liver, there was remaining neoplastic tissue of which the morphology was maintained in H&E staining. This was found to be microwave-fixed non-viable tissue because no enzyme activity of AcP was detected in the infiltrating macrophages. This case report suggests that enzyme histochemistry was useful to assess the effect of MCT, enabling us to distinguish fixed cells from viable cells.

Indexed as

ElectrocoagulationAcid PhosphataseAdenocarcinomaAgedFemaleFrozen SectionsHepatectomyHistocytochemistryHumansLiverLiver NeoplasmsMicrowavesRectal NeoplasmsAcid Phosphatase

Identifiers

PMID12452376
OpenAlexW1942805866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.